Interpretation of Discordant Rifampicin Susceptibility Test Results Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing

BACKGROUND: The 3-month difference in turnaround time between Xpert and conventional phenotypic drug susceptibility testing (pDST) causes patient treatment challenges when pDST rifampin (RIF) susceptibility results and earlier Xpert results disagree, resulting in unnecessary tuberculosis (TB) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Fengmin, Ma, Yifeng, Liu, Rongmei, Ma, Liping, Li, Shanshan, Jiang, Guanglu, Wang, Fen, Shang, Yuanyuan, Dong, Lingling, Pang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397830/
https://www.ncbi.nlm.nih.gov/pubmed/32766385
http://dx.doi.org/10.1093/ofid/ofaa279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397830/
https://www.ncbi.nlm.nih.gov/pubmed/32766385
http://dx.doi.org/10.1093/ofid/ofaa279

Ejemplares similares